Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phreesia (PHR) Cash & Equivalents (2018 - 2025)

Phreesia's Cash & Equivalents history spans 8 years, with the latest figure at $106.4 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 30.13% year-over-year to $106.4 million; the TTM value through Oct 2025 reached $106.4 million, up 30.13%, while the annual FY2025 figure was $84.2 million, 3.77% down from the prior year.
  • Cash & Equivalents for Q4 2025 was $106.4 million at Phreesia, up from $98.3 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $450.7 million in Q2 2021 and bottomed at $79.5 million in Q2 2024.
  • The 5-year median for Cash & Equivalents is $138.7 million (2023), against an average of $190.5 million.
  • The largest annual shift saw Cash & Equivalents surged 422.4% in 2021 before it plummeted 50.68% in 2023.
  • A 5-year view of Cash & Equivalents shows it stood at $400.4 million in 2021, then plummeted by 47.65% to $209.6 million in 2022, then tumbled by 50.68% to $103.4 million in 2023, then dropped by 20.92% to $81.7 million in 2024, then surged by 30.13% to $106.4 million in 2025.
  • Per Business Quant, the three most recent readings for PHR's Cash & Equivalents are $106.4 million (Q4 2025), $98.3 million (Q3 2025), and $90.9 million (Q2 2025).